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ON PROGNOSIS IN PATIENTS UNDERGOING 
CORONARY ARTERY BYPASS SURGERY 
 
Ljubica Georgievska-Ismail, Marija Vavlukis, Vladimir Borozanov 
 
Institute for Heart Diseases, Medical School, Skopje, R. Macedonia 
 
 
A b s t r a c t a : In order to assess the predictive value of left ventricular (LV) 
function on prognosis during 16 years of follow-up we retrospectively/prospectively 
evaluated 320 patients (mean age 55.9 ± 9.2 years; 44 women, 276 men) undergoing 
coronary artery bypass surgery. Patients were divided according to the assessed 
echocardiographically pre- and postoperative LV ejection fraction (LVEF) into two 
groups: patients with LV dysfunction (EF < 55%) and patients with preserved LV 
function (EF ≥ 55%). In order to assess the prognostic variables, patients were further 
subdivided into a group with severely depressed LV function (EF ≤ 35%). Operative 
mortality was 2.0% in patients with LVEF < 55% and 4.5% in patients with LVEF ≤ 
35%, not showing a statistically significant increase of mortality regarding the reduction 
of preoperative assessed EF. In contrast to the preoperative assessed EF, which could 
not be found to be a predictive factor of long-term prognosis, in patients with LV 
dysfunction registered by postoperative assessed EF increased frequency of coronary 
events as well as a shorter time of its occurrence with acceptable long-term survival was 
documented. In patients undergoing surgical myocardial revascularization, symptoms of 
LV failure and postoperative assessed EF were found as independent predictors of 
prognosis.  
We can conclude that surgical myocardial revascularization in patients with 
coronary artery disease and LV failure can be performed safely, providing a relatively 
long-term period of time without coronary events including cardiac death. Postoperative 
assessed LV systolic function appeared as a significant predictor of the clinical 
outcome.  
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Introduction 
 
Patients with severe coronary artery disease (CAD) and symptomatic 
left ventricular (LV) systolic dysfunction have an unfavorable prognosis when 
treated medically, in spite of advances in medical therapy. [1] In this patient 
group surgical revascularization is offered as a safe therapeutic option with an 
acceptably low risk of operative mortality that, in comparison to medical 
treatment alone, shows a significant improvement of LV function, quality of life 
(demonstrated by the improvement in the angina and congestive heart failure 
status) as well as an excellent long-term prognosis. [2, 3] As independent predi-
ctors of postoperative survival many clinical, functional, angiographic and sur-
gical variables have been identified. [1–5] 
The purpose of our study was to assess the predictive value of global 
LV function, represented by pre- and postoperative LV ejection fraction (EF), 
on short- and long-term prognosis in patients with CAD undergoing coronary 
artery bypass surgery. 
  
 
Method 
 
The Institute for Heart Diseases retrospectively-prospectively followed 
up 320 patients with CAD undergoing coronary artery bypass graft surgery 
(CABG) between 1981 and 2002. The patients' baseline information was pro-
vided by interview or query and included age, gender, body mass index, risk 
factors for CAD, previous myocardial infarction, previous stroke, peripheral 
artery disease, type of percutaneous coronary intervention, presence of symp-
toms of angina and/or LV failure as well as medication used. Pre- and posto-
perative the Canadian Cardiovascular Society Functional Classification (CCS) 
was used to stratify the degree of angina. The investigators acquiring the data 
were blinded to the values of LVEF after revascularization. Pre- and postope-
rative physical examination (signs of LV failure) and lipid profile assessment 
were performed. Two-dimensional echocardiography was used in assessment of 
global LVEF by apical four-chamber view and Simpson’s method as well as a 
wall motion abnormalities score index (WMSI) assessment in 16 segments 
using a 5-grade scoring system, i.e. presence of LV thrombus. Color-Doppler 
method was used to assess regurgitation jets, presence of diastolic dysfunction 
and pulmonary hypertension. Coronary angiography was used in assessment of 
the number of stenotic and/or occluded vessels calculated to modify the Gensini 
score as an expression of the angiographic extent of CAD. Data were assessed 
According to the patients’ records operative (number and type of grafts; time, 
place, type and complication of CABG). Postoperative assessment of global and 
segmental LV function was performed or considered valid if it was done 3–6 
 Contribution, Sec. Biol. Med. Sci XXVI/1 (2005) 103–119 
 Predictive value of left ventricular function... 105 
months after revascularization. As for the patients who were retrospectively fol-
lowed up, all pre- and postoperative data regarding non- and invasive exami-
nations were provided from the Institute’s database. All patient information, 
data from personal records and results of examinations were entered into a 
computerized database.  
In order to perform the study, patients were divided into two groups 
according to the registered preoperative global LVEF: Group A (200 pts.) with 
EF < 55% and Group B (120 pts.) with EF ≥ 55%, i.e. according to the registe-
red postoperative global LVEF: Group A1 (42 pts.) with EF < 55% and Group 
B1 (61 pts.) with EF ≥ 55%. In order to assess the prognosis, patients with pre- 
and postoperative LVEF < 55% were further subdivided into two groups: pati-
ents with severely depressed LV function (EF ≤ 35%) and those with a LVEF  
of 36–54%.  
Follow-up was obtained from hospital records, and from interviews 
with the patients or the family and was completed in all 320 patients. Adverse 
cardiac events were defined as follows: cardiac death, acute myocardial 
infarction, LV failure and need for myocardial revascularization (percutaneous 
and/or surgical). 
Statistical analysis. The data were analyzed using SPSS software (ver-
sion 10.0, SPSS INC., Chicago, Illinois). Continuous variables were reported as 
mean ± SD. Categorical variables were reported as counts (percentages) and 
compared between groups using a chi-square test. Continuous variables were 
examined by a two-tailed t test or by the Mann-Whitney U test if not normally 
distributed. The Spearman rank correlation coefficient was used to estimate the 
correlation between variables. Freedom from unfavourable coronary events was 
analysed by means of Kaplan-Meier curves, with differences between groups 
tested by long-rank test. The Cox proportional hazard regression models, using 
a multivariate forward stepping model, were used to examine the time-depen-
dent association between the multiple clinical, echocardiographic and angio-
graphic variables and adverse cardiac event occurrence. The criterion for 
possible inclusion in the Cox hazard model was the existence of a significant 
correlation among variables and adverse cardiac event occurrence, including 
cardiac death. For all analyses a p value < 0.05 was considered statistically 
significant.  
 
Results 
 
Baseline characteristics. The study population (320) was at a mean age 
of 55.9 ± 9.2 years, among them 44 (13.8%) women and 276 (86.3%) men. A 
preoperative comparison between two groups of patients regarding the 
demographic, clinical and angiographic variables, as well as the degree of angina 
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and heart failure status stratified by CCS and NYHA class (Table 1), revealed a 
statistically significant difference only concerning previous myocardial infar-
ction, symptoms of LV failure and presence of peripheral artery disease (more 
frequently present in Group A), and dyslipidemia (more frequently present in 
Group B; p = 0.002). There was no difference between the two groups either in 
the extent of CAD presented by its anatomical distribution or in the frequency 
of percutaneous coronary intervention applied. As for the echocardiographically 
assessed global LV function presented by EF and regional LV function assessed 
by regional asynergy and calculated as a score index of wall motion abnor-
malities (WMSI) as well as for LV internal dimensions, a significant difference 
between the two groups was found. Patients with preoperative LVEF < 55% 
(Group A) had a significantly higher detoriation of their LV function than the 
others (Table 1).  
 
Table 1 ‡ Tabela 1 
 
Comparison of preoperative clinical, angiographic and echocardiographic variables 
 of study population divided according to the registered 
 preoperative LV function 
Sporedba na predoperativnite klini~ki, angiografski  
i ehokardiografski obele`ja na ispituvanata populacija podelena spored 
predoperativno izmerenata LK funkcija 
 
 
Patients with 
EF < 55% 
n = 200 
Patients with  
EF ≥ 55% 
n = 120 
p 
Age (years) 
Gender (m/w %) 
BMI (kg/m2) 
PVD (%) 
HTA (%) 
Smoking (%) 
HLP (%) 
DM (%) 
MI (%) 
Symptoms of LV failure (%) 
CCS score 
Primary PTCA (%) 
Elective PTCA (%) 
Stent implantation (%) 
56.6 ± 9.4 
88.0/12.0 
27.0 ± 3.6 
84.0 
54.8 
60.0 
31.5 
28.0 
70.8 
87.9 
2.5 ± 0.8 
2.5 
9.0 
6.5 
54.9 ± 8.8 
83.3/`6.7 
27.2 ± 3.6 
2.5 
36.1 
75.0 
55.3 
23.7 
88.9 
1.2 ± 0.5 
1.9 ± 0.9 
0 
5.3 
0 
NS 
NS 
NS 
0.043 
NS 
NS 
0.002 
NS 
0.0001 
0.001 
NS 
NS 
NS 
NS 
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Number of stenotic CA 
Left main (%) 
Gensini score 
EF (%) 
LVIDd (mm) 
LVIDs (mm) 
WMSI 
2.4 ± 0.6 
25.8 
19.4 ± 7.6 
38.6 ± 10.3 
59.8 ± 8.1 
44.0 ± 8.9 
1.5 ± 0.5 
2.4 ± 0.6 
20.8 
18.6 ± 7.4 
65.8 ± 7.6 
51.7 ± 4.9 
33.6 ± 4.9 
1.1 ± 0.2 
NS 
NS 
NS 
0.0001 
0.0001 
0.0001 
0.0001 
 
NS = statistically non-significant; BMI = body mass index; PVD = peripheral vascular 
disease; HTA = arterial hypertension; HLP = hyperlipidemia; DM = diabetes mellitus; 
MI = myocardial infarction; LV = left ventricular; CSS = Canadian Cardiovascular 
Society; PTCA = percutaneous transluminal coronary angioplasty; EF = ejection 
fraction; LVIDd = left ventricular internal end-diastolic dimension; LVIDs = left 
ventricular internal end-systolic dimension; WMSI = wall motion score index; MR = 
mitral regurgitation; PAH = pulmonary artery hypertension; 
 
Perioperative characteristics. The patients were operated on in ten 
different operative centres. Mean 2.8 ± 0.9 grafts per patient were applied, most 
often using the left internal mammary artery in combination with vein grafts 
(53.8%) or radial artery (22.5%). In 294 patients classical CABG (using extra 
corporal circulation) was performed and in 26 patients off-pump surgery. 
Statistical analysis of perioperative data (Table 2) revealed that, despite the lack 
of significant difference between the two groups concerning the number of 
grafts used, significant differences were found in the type of conduits used. 
These included greater use of the left internal mammary in combination with the 
radial artery in patients with LVEF < 55% (Group A), i.e. a greater use of vein 
conduits only in Group B. As for associated surgical interventions (frequency of 
aneurysmectomy, endartherectomy, LV reconstruction, annuloplasty of mitral 
and/or tricuspid valve), analysis revealed (Table 2) a lack of significant diffe-
rence between the two groups for almost all interventions except for the annulo-
plasty of the mitral valve which was significantly (p=0.004) more frequently 
used in patients with LVEF < 55% (Group A). Early postoperative complica-
tions (Table 2) as well as intrahospital cardiac death appeared insignificantly 
more frequently in patients with preoperatively EF < 55% in comparison with 
those with LVEF ≥ 55% (2.0% vs. 2.5%; p = NS; respectively). In Group A car-
diac death appeared in 3 patients with EF ≤ 35% (4.1%) which was insignificant 
compared with the rest of the patients, but the more important thing was that 
cardiac death appeared in 12.1% of patients with preoperative presence of sym-
ptoms of LV failure.  
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Table 2 – Tabela 2 
 
Comparison of operative variables of study population divided according  
to the registered preoperative LV function 
Sporedba na operativnite obele`ja na ispituvanata populacija podelena 
spored predoperativno izmerenata LK funkcija 
 
 
Patients with  
EF < 55% 
n = 200 
Patients with  
EF ≥ 55% 
n = 120 
p 
Number of conduits 2.7 ± 0.9 2.7 ± 0.9 NS 
Type of operation (%) 
   - with pump 
   - off-pump 
 
90.5 
8.5 
 
94.2 
5.8 
 
NS 
Type of conduits (%) 
   - LIMA 
   - LIMA+vein graft 
   - LIMA+a.radialis 
   - vein graft 
 
7.6 
55.6 
15.7 
17.7 
 
9.2 
51.7 
3.3 
30.8 
 
 
0.004 
LV reconstraction (%) 14.5 0.8 NS 
Aneurysmectomy (%) 12.0 0 NS 
Endartherectomy (%) 8.6 14.2 NS 
MV annuloplasty (%) 10.0 1.7 0.004 
TV annuloplasty (%) 3.5 0.8 NS 
Early postoperative 
complications (%) 
36.5 29.2 NS 
Intrahospital death (%) 2.5 2.0 NS 
 
NS = statisticaly non-significant; LIMA = left internal mammary artery; LV = left 
ventricular; MV = mitral valve; TV = tricuspid valve;  
 
Postoperative characteristics. The comparison of postoperative echo-
cardiographic measurements revealed a significant difference between the two 
groups of patients for almost all analysed echocardiographic variables (Table 3). 
Patients with preoperative LVEF < 55% in comparison to those patient with 
LVEF ≥ 55% postoperative revealed significantly lower EF (p = 0.0001), higher 
LV internal dimensions (p = 0.0001), and WMSI (p = 0.001). In comparison to 
preoperative value (Figure 1), analysis of echocardiographic data revealed that 
patients with preoperative LVEF < 55% showed postoperative significant 
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improvement of EF, while patients with preoperative LVEF ≥ 55% showed 
postoperative significant deterioration of global and regional LV function 
presented as decreased EF and increased values of the rest of echocardiographic 
measurements, but still within the referential limits (Figure 1). 
Comparison of postoperative frequency of smoking and using aspirin as 
well as statins did not show a significant difference between the two groups 
(Table 3).  
 
Table 3 – Tabela 3 
 
Comparison of postoperative echocardiographical variables and cardiac events occu-
rence of study population divided according to the registered preoperative LV function 
Sporedba na posleoperativnite obele`ja na ispituvanata populacija 
podelena spored predoperativno izmerenata LK funkcija 
 
 
Patients with  
EF < 55% 
n = 200 
Patients with  
EF ≥ 55% 
n = 120 
p 
EF (%) 48.2 ± 16.8 60.9 ± 13.9 0.0001 
LVIDd (mm) 60.6 ± 7.8 51.7 ± 4.9 0.0001 
LVIDs (mm) 43.6 ± 10.9 33.6 ± 4.9 0.001 
WMSI 1.6 ± 0.5 1.3 ± 0.3 0.002 
Smoking (%) 9.6 8.4 NS 
Aspirin (%) 62.4 66.3 NS 
Statins (%) 17.6 26.3 NS 
Cardiac events (%) 17.9 18.8 NS 
Cardiac death (%) 4.6 2.6 NS 
"Hard" events* 9.7 8.5 NS 
LV failure 5.1 2.6 NS 
 
NS = statistically non-significant; EF = ejection fraction; LVIDd = left ventricular 
internal end-diastolic dimension; LVIDs = left ventricular internal end-systolic dimen-
sion; WMSI = wall motion score index;  
* Cardiac death, acute myocardial infarction and/or LV failure; 
Prilozi, Odd. biol. med. nauki XXVI/1 (2005) 103–119 
110 Lj. Georgievska-Ismail, M. Vavlukis, V. Borozanov 
 
0
10
20
30
40
50
60
70
EF LVIDd LVIDs WMSI EF LVIDd LVIDs WMSI
Group A Group B
 
Figure 1 – Echocardiographic variables of LV function before and after surgical 
revascularization of study population divided according 
 to the registered preoperative LV function 
Grafikon 1 ‡ Ehokardiografski obele`ja na LK funkcija  
pred i po hirur{ka revaskularizacija na ispituvanata populacija 
podelena spored predoperativno izmerenata LK funkcija 
 
EF = ejection fraction; LVIDd = left ventricular internal end-diastolic dimension; 
LVIDs = left ventricular internal end-systolic dimension; WMSI = wall motion score 
index;  
* Group A preoperatively in comparison to postoperative assessed EF, p = 0.001;  
* Group B preoperatively in comparison to postoperative assessed : EF, p = 0.007; 
LVIDd, p = 0.017; LVIDs p = 0.007; WMSI, p = 0.007  
 
 Postoperative outcome. Comparison of patients divided according to 
preoperatively assessed LVEF (Table 3) showed a lack of any statistically 
significant difference in the frequency of postoperative cardiac events occur-
rence (35 patients in Group A versus 23 patients in Group B; p = 0.473) as well 
as for the cardiac death (9 patients in Group A versus 3 patients in Group B; p = 
0.281). These findings were also confirmed when only "hard" events (cardiac 
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death, acute myocardial infarction, LV failure) were considered (19 patients in 
Group A versus 10 patients in Group B; p = 0.451). Comparison of the event-
free survival time in the two groups of patients again confirmed lack of any 
significant difference either to overall adverse cardiac events (p = 0.089) or the 
"hard" ones (p = 0.080) or to cardiac death (p = 0.074). In order to assess the 
existence of a possible difference in event-free survival time in patients with 
severely depressed LV function (EF ≤ 35%) in comparison to patients with 
moderate LV dysfunction (EF = 36–54%) and those with preserved LV function 
(EF ≥ 55%), we performed a Kaplan-Meyer analysis. The results showed that 
patients with severely depressed LV function (EF ≤ 35%) in comparison to the 
other two groups of patients had a significantly shorter time to cardiac death 
occurrence (p = 0.019; Figure 2), but with acceptable long-term survival. 
 
 
Years
50
C
um
 S
ur
vi
va
l
1.0
.9
.8
.7
.6
.5
.4
.3
.2
.1
0.0
9
Figure 2 – Kaplan-Meier curves for
 of study population divided accordi
Grafikon 2 ‡ Kaplan-Meier krivi
na smrt kaj ispituvanata popul
izmeren
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 On the other hand, comparison of patients divided according to 
postoperative assessed LVEF (Table 4) showed a significant difference in the 
frequency of overall adverse cardiac events (22 patients in Group A1 versus 14 
patients in Group B; p = 0.003) or the "hard" ones (12 patients in Group A1 
versus 4 patients in Group B; p = 0.004) as well as in LV failure occurrence (8 
patients in Group A1 versus 4 patients in Group B; p = 0.003) in favour of 
patients with LVEF < 55% (Group A1), but without any statistical difference 
for cardiac death (3 patients in Group A1 versus 1 patient in Group B; p = 
0.302). As for the comparison of the time to events soccurrence in patients 
divided according to postoperative assessed LVEF, a significanty worse prog-
nosis was found for the patients with LVEF < 55% . The time to the overall 
cardiac events' occurrence (Figure 3), including the "hard" ones, LV failure or 
cardiac death (Figure 4), was significantly shorter in this patient group (p = 
0.0007; p = 0.0004; p = 0.001; p = 0.028; respectively), in spite of a relatively 
good long-term survival (median time of survival for patients with LVEF < 
55% was 12 years). In comparison to patients with preserved LV function (EF ≥ 
55%), a significantly shorter time to the overall events' occurrence as well as to 
"hard" ones was found either in patients with postoperative LVEF ≤ 35% (p = 
0.001; p = 0.001; respectively) or with EF of 36–54% (p = 0.01; p = 0.037; 
respectively), while a significantly shorter time to cardiac death and LV failure 
occurrence was found only in patients with severely depressed LV function (EF 
≤ 35%) in comparison to patients with LVEF ≥ 55% (p = 0.03; p = 0.0001; res-
pectively). The median time of survival for patients with LVEF ≤ 35% was 10 
years, for those with LVEF of 36–54% was 12 years and for patients with 
LVEF ≥ 55% it was 17 years. 
After performing a correlation analysis of demographic, pre- and 
postoperative clinical, echocardiography and angiographic variables, potential 
predictors of adverse cardiac events, including cardiac death, were identified 
and entered in Cox proportional hazard models. After adjustment for other 
factors, the preoperative presence of the symptoms of LV failure was identified 
as an independent predictor of intrahospital cardiac death (p = 0.0001), while 
the postoperative echocardiographically assessed LV systolic internal dimen-
sion as well as LVEF were revealed as independent predictors of overall cardiac 
events' occurrence (p = 0.0001). As for postoperative cardiac death, the most 
significant predictors of its occurrence were the preoperative presence of sym-
ptoms and signs of LV failure and postoperative complications (p = 0.002). 
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Discussion 
 
At the end of seventies of the last century surgical coronary revascu-
larization became standard therapy for patients with multivessel CAD and 
severe myocardial ischemia. As a result of several clinical studies this thera-
peutic option appeared as an extremely useful procedure for patients with mo-
derate to severe LV dysfunction, although at the expense of higher perioperative 
mortality. [1–5] 
 A number of demographic, clinical and imaging variables have been 
identified as predictive factors of a higher operative mortality rate in patients 
with impaired LV function, such as: emergency of surgical operation; low EF; 
higher end-diastolic LV pressure; worse wall motion abnormalities score index 
(WMSI); higher left main stenosis; advanced age; female gender; previous 
coronary bypass surgery etc. [6–10]  The majority of studies have revealed that 
operative mortality progressively increases with a lowering of EF to below 
40%, reaching the highest value in patients with an EF below 20%. However, 
few studies came to the notion that the operative mortality rate increases along 
with the extent of heart failure symptoms, no meter of objective extent of LV 
dysfunction being represented by decreased EF. [2, 9] 
The results of our study showed that intrahospital mortality rate in the 
overall population was 2.2% which is within the limits issued in the literature 
(around 3%), i.e. 2% in patients with EF < 55% and 4.1% in patients with EF ≤ 
35%, but without any statistically significant increase of mortality with a de-
crease of preoperatively assessed EF. Such results are possibly related to appli-
cation of CABG in a highly selected population with LV dysfunction that have 
few associated diseases as well as to complete revascularization, especially 
arterial which was in this group of patients more often applied. However, intra-
hospital mortality appeared significantly more often in patients with a preo-
perative presence of symptoms of LV failure (12.1% in patients with symptoms 
vs. 1% in patients without; p = 0.0001). Although analysis of preoperatively as-
sessed variables showed the existence of a significant correlation between mor-
tality and advanced age, symptoms of LV failure, echocardiogaphically asses-
sed higher LV end-diastolic dimension and aneurismectomy, Cox-regression 
analysis revealed that only the presence of symptoms of LV failure was iden-
tified as an independent predictive factor of intrahospital mortality, which led to 
a risk of 5% in those patients who had them. 
In the literature, evidence from randomized studies that could confirm 
the positive impact of CABG on LV failure symptoms improvement is still 
lacking, but results of observational studies has revealed that the application of 
CABG could improve the symptoms, i.e. stabilize and improve LV function, 
exercise-tolerance and/or extend the long-term survival in selected patients with 
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the presence of a relevant amount of viable myocardium which is vascularized 
by adequate coronary arteries that could be bypassed. [1, 8, 11–13 ] Analysis of 
data from CASS registry and Duke University Cardiovascular Database regar-
ding 5- and 10-year survival rates of patients with LV failure revealed that 5-ye-
ars survival in patients revascularized by CABG was 63% versus 43% in 
patients medically treated. Yet, patients with EF ≤ 35% had the most benefit 
from CABG with a 10-year survival rate of 46% versus 27% in medically 
treated ones. [11] However, in part of this population group, a beneficial effect 
of CABG on the clinical outcome could not be found; even some increase in 
frequency of adverse cardiac events' occurrence, including death could be de-
monstrated. Therefore, having the possibility to identify patients with LV 
dysfunction who could most benefit from surgical revascularization becomes 
extremely important.  
For many years now, a number of clinical and non-invasive imaging 
methods have been used, whose essential goal was to identify predictive factors 
of postoperative symptom improvement and better long-term prognosis in 
patients with LV dysfunction. Therefore many factors have been identified: age, 
diabetes mellitus, previous CABG, time to surgical revascularization, functional 
impairment assessed by NYHA and/or LVEF, i.e. percentage of viable myocar-
dium and/or amount of a myocardial scar. [4, 12, 13]  
The results of our study revealed the lack of a statistically significant 
difference in the frequency as well as the time free of adverse cardiac events' 
occurrence, including cardiac death in patients divided according to preope-
ratively assessed LVEF (LVEF < 55% and ≥ 55%). However, when we analyse 
the same patients further divided into severe (EF ≤ 35%) and moderate (36–
54%) LV dysfunction, the results revealed a statistically significant shorter time 
to cardiac death occurrence, but with acceptable long-term survival in patients 
with EF ≤ 35% in comparison to those with EF ≥ 55% (p = 0.019; Figure 2). 
These results are probably due to a higher percent of intrahospital cardiac death 
in patients with LVEF ≤ 35%, and acceptable long-term survival to the fact that 
patients with LVEF < 55% postoperative showed significant improvement of 
LV function in relation to preoperative values (Figure 1). On the other hand, in 
patients divided according to postoperative assessed LVEF, the comparison 
analysis revealed more frequent adverse cardiac events' occurrence, but without 
cardiac death in patients with EF < 55%. As for analysis of the time to event 
occurrence in patients divided according to the postoperative assessed LVEF, a 
significantly by worse prognosis was found for the patients with LVEF < 55% 
(Figure 3 and 4). In comparison to patients with preserved LV function (EF ≥ 
55%), the time to overall cardiac events' occurrence was significantly shorter 
both in patients with LVEF ≤ 35% and in those with LVEF of 36–54%, while a 
significantly shorter time to cardiac death occurrence as well as signs and 
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symptoms of LV failure appeared only in patients with severe LV dysfunction 
(LVEF ≤ 35%). However, besides a relatively worse prognosis, acceptable 
long-term survival has been identified both in patients with LVEF < 55% and in 
those with postoperative severely impaired LV function (EF ≤ 35%).  
The results of our study revealed that the preoperative presence of 
symptoms of LV failure as well as postoperative assessed LVEF appeared as 
most significant independent predictors of prognosis in patients after surgical 
revascularization.  
 
 
Limitation of the study 
  
 The potential limitation of the present study was the low mortality rates 
encountered in our cohort which could represent the limitation factor to detect 
differences and/or assess prognosis according to certain predictive variables. 
However, the satisfactory number of patients and its long-term follow-up, 
provide a real base for interpretation of the results of the study. 
 
 
Conclusion 
 
 The results of our study revealed that surgical coronary revasculariza-
tion in patients with CAD and LV dysfunction, although carrying a higher risk 
of operative and postoperative adverse cardiac events' occurrence and/or cardiac 
death, can be performed as a therapeutically safe option, providing a relatively 
long-term period of time without coronary events including cardiac death.  
 Symptoms of LV failure appeared as a significant independent predictor 
of intrahospital as well as postoperative mortality, while postoperative assessed 
LVEF as a representative of LV systolic function, appeared as significant 
independent predictor of the long-term clinical outcome in patients with surgical 
coronary revascularization. 
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PRETSKA@UVA^KA VREDNOST NA LEVOKOMORNATA 
FUNKCIJA VRZ  PROGNOZATA KAJ PACIENTI  
PO KORONARNA BAJPAS  HIRURGIJA 
 
Qubica Georgievska-Ismail, Marija Vavlukis, Vladimir Borozanov 
 
Institut za srcevi zaboluvawa, Medicinski fakultet,  
Skopje, R. Makedonija 
 
So cel da se proceni pretska`uva~kata vrednost na levo komornata 
(LK) funkcija vrz prognozata, retrospektivno-prospektivno vo tek na 16 
godini bea sledeni 320 pacienti (sredna vozrast od 55.9 ± 9.2 godini; 44 
`eni i 276 ma`i) po koronarna bajpas hirurgija. Pacientite bea podelu-
vani na dve grupi spored pred- i posleoperativno ehokardiografski regi-
striranata ejekciona frakcija (EF): pacienti so naru{ena LK funkcija 
(EF < 55%) i pacienti so so~uvana LK funkcija (EF ≥ 55%), a prognosti~-
kite efekti na obele`jata bea ispituvani i kaj pacientite so zna~ajno 
naru{ena LK funkcija (EF < 35%). Bolni~ka smrtnost be{e zabele`ana 
kaj  2.0% od pacientite so EF < 55% i 4.5% kaj pacientite so EF < 35%, 
{to ne pretstavuva{e statisti~ki zna~ajno zgolemuvawe na smrtnosta so 
namaluvawe na predoperativno procenetata  EF. Za razlika od predopera-
tivno procenetata EF koja{to ne se poka`a kako diskriminatoren faktor 
na dolgoro~nata prognoza, kaj pacientite so LK disfunkcija registrirana 
so posleoperativno procenetata EF be{e najdena, kako zgolemena ~estota 
na pojava na nesakani zbidnuvawata, taka i pokratko vreme do nivnata poja-
va, no so zadovolitelno dolgoro~no pre`ivuvawe. Simptomite na LK sla-
bost i posleoperativno procenetata EF se izdvoija kako najzna~ajni neza-
visni pretska`uva~i vo predviduvaweto na prognozata na pacientite po 
hirur{ka revaskularizacija na miokardot.  
 Bi mo`ele da zaklu~ime deka hirur{kata revaskularizacija na 
miokardot kaj pacientite so KAB i LK disfunkcija, iako nosi pogolem 
rizik za pojava na operativni i posleoperativni nesakani zbidnuvawa 
i/ili smrt mo`e da se primeni kako sigurna terapevtska opcija, pri {to 
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obezbeduva relativno dolg period osloboden od nesakani koronarni zbid-
nuvawa, vklu~uvaj}i ja i smrtta. Posleoperativno procenetata LK sistol-
na funkcija pretstavuva zna~aen pretska`uva~ na klini~kiot tek. 
 
Klu~ni zborovi: levo komorna slabost, koronarna bajpas hirurgija, prog-
noza.  
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